Jonas Bouhlal

4PUBLICATIONS
38CO-AUTHORS
Molecular targetsHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 27, 2026
Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

|Jan 10, 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Petra Nygrén, Jonas Bouhlal, Emmi Jokinen

|Nov 03, 2023
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Jani Huuhtanen, Shady Adnan-Awad, Jason Theodoropoulos

|Dec 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela

Pageof 1

Frequent Collaborators

4 joint publications

Olli Dufva

4 joint publications

Satu Mustjoki

3 joint publications

Shady Adnan-Awad

2 joint publications

Essi Laajala